Highlights from the 2015 North American Cystic Fibrosis Conference-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Highlights from the 2015 North American Cystic Fibrosis Conference

Published:2016-04-13 Issue:6 Volume:51 Page:650-657
ISSN:8755-6863
Container-title:Pediatric Pulmonology
language:en
Short-container-title:Pediatr Pulmonol.

Author:

Zemanick Edith T.¹,Ong Thida²,Daines Cori L.³,Dellon Elisabeth P.⁴,Muhlebach Marianne S.⁴,Esther Charles R.⁴

Affiliation:

1. Department of Pediatrics; University of Colorado School of Medicine; Aurora Colorado

2. Division of Pulmonary and Sleep Medicine; Department of Pediatrics; Seattle Children's Hospital; University of Washington; Seattle Washington

3. Department of Pediatrics; University of Arizona College of Medicine; Tucson Arizona

4. Division of Pulmonology; Department of Pediatrics; University of North Carolina at Chapel Hill; Chapel Hill North Carolina

Funder

Cystic Fibrosis Foundation

Publisher

Wiley

Subject

Pulmonary and Respiratory Medicine,Pediatrics, Perinatology, and Child Health

Reference32 articles.

1. From CFTR biology toward combinatorial pharmacotherapy: expanded classification of cystic fibrosis mutations;Veit;Mol Biol Cell,2016

2. Synthetic aminoglycosides efficiently suppress cystic fibrosis transmembrane conductance regulator nonsense mutations and are enhanced by ivacaftor;Xue;Am J Respir Cell Mol Biol,2014

3. Lumacaftor-ivacaftor in patients with cystic fibrosis homozygous for Phe508del CFTR;Wainwright;N Engl J Med,2015

4. Safety, pharmacokinetics, and pharmacodynamics of ivacaftor in patients aged 2-5 years with cystic fibrosis and a CFTR gating mutation (KIWI): an open-label, single-arm study;Davies;Lancet Respir Med,2016

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cystic fibrosis transmembrane conductance regulator modulators: Present and future in cystic fibrosis treatment. A review;Archivos Argentinos de Pediatria;2019-04-01

2. Molecular Epidemiology of Methicillin-Resistant Staphylococcus aureus in Cystic Fibrosis Patients from Argentina;Microbial Drug Resistance;2018-06

3. Highlights from the 2016 North American Cystic Fibrosis Conference;Pediatric Pulmonology;2017-07-11

4. Therapeutic challenges posed by critical drug-drug interactions in cystic fibrosis;Pediatric Pulmonology;2016-09-23

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3